← Back to Clinical Trials
Recruiting NCT05141591

NCT05141591 Gender-specific Preoperative Anxiety Level and Postoperative Opioid Requirement After ENT Surgery.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05141591
Status Recruiting
Phase
Sponsor Medical University of Vienna
Condition Anxiety
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2021-11-11
Primary Completion 2026-12-29

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Anxiety level assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2021-11-11 with a primary completion date of 2026-12-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will be designed to investigate the impact of the preoperative anxiety level on postoperative opioid requirement during the PACU stay, in order to improve postoperative pain treatment in the long term after ENT surgery. The present study can contribute to improve postoperative pain management in patients in the field of ENT surgery, as new influencing parameters and risk factors may be discovered.

Eligibility Criteria

Inclusion Criteria: * American Society of Anesthesiology (ASA) physical status I-IV * able to read and understand the information sheet and to sign the consent form * being scheduled for elective ENT surgery under general anesthesia * written informed consent * age≥18 years Exclusion Criteria: * difficulty to understand study procedure, pain scoring system or questionnaires * surgical procedure warranting elective postoperative ventilation

Contact & Investigator

Central Contact

Marita Windpassinger, MD

✉ marita.windpassinger@meduniwien.ac.at

📞 +43 1 40400 41020

Frequently Asked Questions

Who can join the NCT05141591 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05141591 currently recruiting?

Yes, NCT05141591 is actively recruiting participants. Contact the research team at marita.windpassinger@meduniwien.ac.at for enrollment information.

Where is the NCT05141591 trial being conducted?

This trial is being conducted at Vienna, Austria.

Who is sponsoring the NCT05141591 clinical trial?

NCT05141591 is sponsored by Medical University of Vienna. The trial plans to enroll 300 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology